• But Pfizer and Bristol-Myers Squibb, one with a new boss and the other still looking, had better be taking notes.

    FORBES: Taking Their Medicine

  • Merck, Eli Lilly, Pfizer and Bristol-Myers Squibb now are yield stocks with just some promise of financial engineering like stock buybacks and dispositions of stagnant divisions.

    FORBES: Open Season On Icons, From Apple And Google To Charlie Sheen

  • Pfizer and partner Bristol-Myers Squibb Co. will promote it jointly, noting its advantages over two rival drugs on the market already, Xarelto and Pradaxa.

    WSJ: Pfizer Q4 net jumps on sale of nutrition business

  • In cholesterol-lowering drugs, one of the biggest categories, generic versions of Lipitor, Zocor, and Pravachol, once sold by Pfizer, Merck, and Bristol-Myers Squibb, now account for 64% of all cholesterol drug sales.

    FORBES: Oh, Come On: Pharma Whinges About Government Drug Sales Force.

  • Already companies like Pfizer, Merck and Bristol-Myers Squibb are quietly drawing new battle lines.

    FORBES: Magazine Article

  • These drugs, the statins, are the top sellers for Pfizer , Merck and Bristol-Myers Squibb .

    FORBES: Magazine Article

  • However, it's very existence shows how heart drugs, once the province of Pfizer, Merck and Bristol-Myers Squibb (nyse: BMY - news - people ), are increasingly being developed at small biotechs like Esperion or Alpharetta, Ga.

    FORBES: Magazine Article

  • So far, Zetia is being used both alone and in combination with a mix of other cholesterol drugs, including Zocor, Pfizer's Lipitor and Bristol-Myers Squibb 's (nyse: BMY - news - people ) Pravachol.

    FORBES: Magazine Article

  • Pfizer's drug tremelimumab and Bristol-Myers Squibb's ipilimumab are antibodies to a protein called CTLA-4 (cytotoxic T-lymphocyte antigen-4) that acts as an emergency brake to prevent killer T cells from attacking healthy tissue.

    FORBES: Targeting Melanoma

  • But in February a panel convened by the American Diabetes Association published a paper saying that Zyprexa is far more likely than peers such as Geodon, from Pfizer, and Abilify, from Bristol-Myers Squibb and Otsuka, to cause weight gain, diabetes and high cholesterol.

    FORBES: Lilly's Big Fat Risk

  • Big drug companies, including Pfizer, Bristol-Myers Squibb and Sanofi-Aventis, are doggedly pursuing drugs that aim to boost the immune system to fight cancer.

    FORBES: Magazine Article

  • The drugs, in testing at Pfizer, Bristol-Myers Squibb and elsewhere, may improve upon medicine's dismal track record of treating the most deadly form of skin cancer.

    FORBES: Magazine Article

  • Big pharmaceutical companies like Pfizer, Bristol-Myers Squibb, and Novartis have been knowingly veering away from mass-market drugs.

    FORBES: What Gifts Should Obama Give Big Pharma?

  • Another related drug, called apixaban from Bristol-Myers Squibb and Pfizer, might have less bleeding when clinical trial results read out next year.

    FORBES: Names You Need To Know: Pradaxa and Xarelto

  • If Xarelto is not approved to prevent strokes in patients with atrial fibrillation, a heart rhythm disorder, Bristol-Myers Squibb and Pfizer could benefit if their drug, Eliquis, does reach the market.

    FORBES: Xarelto Runs The Gauntlet

  • The market for cholesterol drugs is expected to continue to grow, even though cholesterol medicines made by Merck (nyse: MRK - news - people), Pfizer (nyse: PFE - news - people) and Bristol-Myers Squibb (nyse: BMY - news - people)are already some of the world's most lucrative drugs.

    FORBES: Magazine Article

  • In the first, HERE, Smith explains why amyloid drugs from Bristol-Myers Squibb, Pfizer, and others may be dangerous.

    FORBES: Are Alzheimer's Drugs From Bristol-Myers and Pfizer Safe? A Debate

  • Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca and others are testing drugs that would reduce inflammation indirectly by raising the "good" HDL cholesterol that helps the body pump fat out of the arteries.

    FORBES: Attacking Heart Attacks

  • Bristol-Myers Squibb ( BMY) and Pfizer ( PFE) announced over the weekend positive results in a Phase 3 trial that compared Elquis to warfarin for the prevention of stroke or systemic embolism in patients with atrial fibrillation and at least one risk factor for stroke.

    FORBES: Bristol-Myers, Pfizer Announce Positive Results; An FDA Approval for Pfizer

  • That drug wasn't even the leader in the cholesterol-fighting pack, led by Merck (nyse: MRK - news - people), Pfizer (nyse: PFE - news - people), and Bristol-Myers Squibb (nyse: BMY - news - people).

    FORBES: Magazine Article

  • He said Pfizer will soon launch two new medicines, rheumatoid arthritis treatment Xeljanz and with partner Bristol-Myers Squibb Co.

    WSJ: Pfizer Q4 net jumps on sale of nutrition business

  • Read told analysts during a conference call that Pfizer will soon launch two new medicines, rheumatoid arthritis treatment Xeljanz and with partner Bristol-Myers Squibb Co.

    WSJ: Pfizer Q4 net jumps on sale of nutrition business

  • The drugs, in testing at Pfizer, Bristol-Myers Squibb (nyse: BMY - news - people ) and elsewhere, may improve upon medicine's dismal track record of treating the most deadly form of skin cancer.

    FORBES: Targeting Melanoma

  • In the past four years, AstraZeneca ( AZN), Pfizer ( PFE), Eli Lilly ( LLY), Bristol-Myers Squibb ( BMY) and Forest Labs ( FRX) have all settled federal charges of marketing psychoactive drugs off-label, at a cost running into hundreds of millions.

    FORBES: Bad Side-Effects Ahead For Pharma?

  • Meanwhile, Zyprexa, the top seller for giant Eli Lilly, has seen its annual sales drop slowly in recent years as competitors such as Pfizer 's (nyse: PFE - news - people ) Geodon and Abilify, from Bristol-Myers Squibb (nyse: BMY - news - people ), have boasted that they cause less weight gain.

    FORBES: Jazz, Schizophrenia And Side Effects

  • Helped by recent news of a weak economy and record low interest rates, the stocks of major pharmaceutical companies like Abbott Labs (NYSE:ABT), Lilly Eli (NYSE:LLY), Pfizer (NYSE:PFE), Merck (NYSE:MRK), and Bristol Myers Squibb traded near 52-week highs this morning.

    FORBES: Pharmaceuticals Trading Near 52-Week Highs

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定